Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition, vaginal gel prepared from composition and application of composition in resisting human papilloma viruses

A vaginal gel and composition technology, applied in the field of anti-human papillomavirus products, can solve problems such as side effects, insufficient effect of eliminating HPV, hidden safety hazards, etc., achieve good biocompatibility, good subjective experience, and easy to use comfortable effect

Active Publication Date: 2020-12-04
南京北极光生物科技有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The anti-HPV products containing β-glucan in the prior art have insufficient effect on removing HPV; and hormones and interferons (such as recombinant human interferon α-2b) are added on the basis of β-glucan , extracts or chemically synthesized drugs, etc., on the one hand, there are safety hazards and side effects, which affect the beneficial bacteria in the vagina; on the other hand, for anti-HPV gel products containing β-glucan, the added Substances are unfavorable to the formation of gel dosage forms, and the physical and chemical properties of the additives need to be considered, and the stability is relatively poor; making the process of preparing gel dosage forms relatively complicated

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition, vaginal gel prepared from composition and application of composition in resisting human papilloma viruses
  • Composition, vaginal gel prepared from composition and application of composition in resisting human papilloma viruses
  • Composition, vaginal gel prepared from composition and application of composition in resisting human papilloma viruses

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] A gel containing β-glucan and hyaluronic acid, 6 parts of β-glucan and 4 parts of hyaluronic acid.

[0051] As a test gel for anti-HPV effect: prepared from β-glucan and hyaluronic acid, the content of β-glucan is 18mg / g, and the content of hyaluronic acid is 12mg / g; the average of β-glucan The molecular weight is 100,000 to 1,000,000, about 500,000; the average molecular weight of hyaluronic acid is 750,000 to 1,000,000, about 800,000.

[0052] HeLa cell is the cancer cell that is transformed into by normal cervical cell, in the present invention, as the infection object of HPV pseudovirus, prepares Hela cell suspension in conventional manner; Prepare HPV16 pseudovirion particle in conventional manner; Anti-HPV gel dilution 10 times as the original dilution solution of anti-HPV gel, the inhibitory effect test of anti-HPV virus on HPV virus activity.

[0053] (1) Add 100 μl of cell suspension to a 96-well microculture plate to make the cell volume reach 100,000 / ml. Fo...

Embodiment 2

[0062] A gel containing β-glucan and hyaluronic acid, 5 parts of β-glucan and 5 parts of hyaluronic acid.

Embodiment 3

[0064] A gel containing β-glucan and hyaluronic acid, 3 parts of β-glucan and 7 parts of hyaluronic acid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition, vaginal gel prepared from the composition and application of the composition in resisting human papilloma viruses. The gel comprises the effective components ofbeta-glucan and hyaluronic acid, and the beta-glucan and hyaluronic acid are both carriers of gel products and are anti-human papilloma virus functional components of the gel products. And moreover, the the beta-glucan and hyaluronic acid have quite high biocompatibility and almost have no toxic or side effect. The beta-glucan and hyaluronic acid have the effect of synergistically resisting humanpapilloma viruses, and have the advantages of being stable, moderate in viscosity, comfortable to use and free of influence on vaginal bacteria.

Description

technical field [0001] The invention relates to the technical field of gynecological care products, in particular to a vaginal gel anti-human papillomavirus product. Background technique [0002] High-risk HPV infection can easily lead to cervical intraepithelial neoplasia and cervical cancer. Effective intervention in the early stage of HPV infection is of great significance to improve the prognosis. Among them, the long-term infection of HPV16 and HPV18 subtypes has been proved to be a major cause of cervical cancer. At present, there is no specific preventive drug against HPV on the market, and the HPV vaccine is mainly suitable for women who have not had sexual activity. Therefore, it is of great significance to develop new anti-HPV health care products and medicines. Interferon commonly used in drug treatment of cervical HPV infection, such as Xinfuning (recombinant human interferon ɑ2b vaginal effervescent capsule), theoretically induces the production of antiviral p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K31/716A61K31/728A61P15/02A61P31/20
CPCA61K9/06A61K9/0034A61K31/716A61K31/728A61P15/02A61P31/20A61K2300/00Y02A50/30
Inventor 陆启东李靖付修远孙雨薇
Owner 南京北极光生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products